Mass Spectra of Designer Drugs 2013

Author:   Peter Rosner
Publisher:   Wiley-VCH Verlag GmbH
ISBN:  

9783527334001


Pages:   250
Publication Date:   17 May 2013
Format:   Digital
Availability:   To order   Availability explained
Stock availability from the supplier is unknown. We will order it for you and ship this item to you once it is received by us.

Our Price $5510.00 Quantity:  
Add to Cart

Share |

Mass Spectra of Designer Drugs 2013


Overview

Compounds classified as Designer Drugs have been synthesized for several decades. This is not a precise scientific term and should only be applied to those drugs that are synthesized from common chemicals and skillfully marketed under attractive, often exotic names. Because of many designer drugs are novel or designed to evade detection, they can be overlooked or difficult to detect or characterize. The last decade has seen a proliferation of such substances, such that keeping abreast of this huge number of new drugs is a difficult task for forensic chemists and toxicologists. Compiled by a team originating from the Regional Departments of Criminal Investigation in Kiel, Hamburg, and Wiesbaden, Germany, Mass Spectra of Designer Drugs has been developed to help forensics and toxicology labs combat this epidemic. Mass Spectra of Designer Drugs 2013 covers the entire range of designer drugs up to December 2012. Approximately 70% of the compounds covered in the Designer Drugs do not appear in either NIST 2011 or the Wiley Registry of Mass Spectral Data, 9th Edition . Specifications: Spectra Mass Spectra: 19,037 Compounds: 15,556 Structures: 19,037 TSQ-spectra: 9,345 GCQ-spectra: 1,146 CI-spectra: 468 HP-spectra: 1,184 TRACE-spectra: 1,220 GC/MS spectra: 18,856 Direct insert mass spectra: 181 Number of CAS numbers: 5,927 (31.1%) Number of measured Kovats Indices: 11,061 (58.1%) Number of indication information: 16,367 (86.0%) Number of verified MS: 2,128 (11.2%) Number of verified MS by independent measurement: 3,192 (16.8%) Average Peaks/Spectrum: 169.5 Average Quality Index/Spectrum: 940.5 Replicate Spectra (same interfacing/ionization mode/system): 512 <=(2.7%) Compound Coverage Compound coverage for individual compounds can be verified at www.compoundsearch.com : Amphetamines: 1,469 Methylenedioxyphenethylamines: 666 Phenethylamines: 2,014 Tryptamines: 462 Piperazines: 904 Opiates: 259 Fentanyles: 320 Cathinones: 504 Phencyclidines: 16 Tropines: 97 Indoles: 894 Barbiturates: 79 Cannabinoids: 255 Cannabimimetics: 528 Steroids: 190 arylpropan-2-amines: 266 arylbutan-2-amines: 433 indane-2-amines: 67 1-aryl-2-nitro-ethenes: 43 1-aryl-2-nitroprop-1-enes: 68 1-aryl-2-nitrobut-1-ene: 44 Benzaldehydes: 150 Derivatives: 5,724 Metabolites incl. derivatives: 4,136 Chemical warfare agents: 71 Designer drug precursors: 1,158 Benzodiazepines: 272 Pharmaceutical drugs incl. metabolites: 4,460 Pesticides: 315 Explosives: 53 Controlled compounds: 2,621 Compatibility Compatible with most current and legacy mass spectrometry data systems, including: ACD/Labs MS Manager Agilent Chemstation, MassHunter Bruker/Varian JEOL Leco NIST MS Search PerkinElmer TurboMass Shimadzu GCMS Solution ThermoScientific INCOS/GCQ, Spectral ID, XCalibur Waters MassLynx

Full Product Details

Author:   Peter Rosner
Publisher:   Wiley-VCH Verlag GmbH
Imprint:   Wiley-VCH Verlag GmbH
Weight:   0.001kg
ISBN:  

9783527334001


ISBN 10:   3527334009
Pages:   250
Publication Date:   17 May 2013
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Digital
Publisher's Status:   Active
Availability:   To order   Availability explained
Stock availability from the supplier is unknown. We will order it for you and ship this item to you once it is received by us.

Table of Contents

Reviews

Author Information

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

RGJ26

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List